Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$122.70

-1.39 (-1.12%)

12:55
04/16/19
04/16
12:55
04/16/19
12:55

Cantor specialty pharma analyst to hold an analyst/industry conference call

Specialty Pharmaceuticals Analyst Chen discusses where Eli Lilly's LOXO-292 fits in the paradigm for RET-driven cancers on an Analyst/Industry conference call to be held on April 16 at 1:30 pm.

  • 16

    Apr

  • 30

    Apr

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

LLY Eli Lilly
$122.70

-1.39 (-1.12%)

04/11/19
04/11/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Chipotle (CMG) downgraded to Hold from Buy at Jefferies with analyst Andrew Barish saying after rallying 65% in Q1, Chipotle's valuation is full and reflects improved visibility for "powerful" same-store-sales and margin drivers. 2. Eli Lilly (LLY) downgraded to Neutral from Buy at Guggenheim with analyst Seamus Fernandez saying while he expects updates at the American Diabetes Association meeting to be broadly positive, he sees limited upside for the stock from current levels until Lilly's overall immunology portfolio and competition from Novo Nordisk's (NVO) semaglutide franchise is more fully understood. 3. U.S. Steel (X) downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners citing worse near-term U.S. market conditions than she anticipated. 4. Keurig Dr Pepper (KDP) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying she sees a negative risk-reward despite a "well telegraphed" Q1 earnings beat on strong pricing at heritage Dr. Pepper Snapple. 5. Waste Management (WM) downgraded to Hold from Buy at Stifel with analyst Michael Hoffman saying he factors in incrementally weaker paper prices and the impact of wet weather. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/11/19
GUGG
04/11/19
DOWNGRADE
GUGG
Neutral
Guggenheim sees limited upside for Eli Lilly, downgrades to Neutral
As previously reported, Guggenheim analyst Seamus Fernandez downgraded Eli Lilly (LLY) to Neutral from Buy, stating that while he expects updates at the American Diabetes Association meeting to be broadly positive, he sees limited upside for the stock from current levels until Lilly's overall immunology portfolio and competition from Novo Nordisk's (NVO) semaglutide franchise is more fully understood. Though he still thinks Eli Lilly has "the best long-term growth profile in US Pharma," that growth is the broad consensus view, said Fernandez, who removed his price target on the stock but estimates the fair value to be in the range of $125-$135 per share.
04/11/19
GUGG
04/11/19
DOWNGRADE
GUGG
Neutral
Eli Lilly downgraded to Neutral from Buy at Guggenheim
03/21/19
BMOC
03/21/19
NO CHANGE
BMOC
Outperform
Biogen Alzheimer's news incrementally negative for Eli Lilly, says BMO Capital
BMO Capital analyst Alex Arfaei said Biogen's (BIIB) report of the failure of aducanumab weakens, if not removes, a potential source of upside for Eli Lilly (LLY), which has an "aducanumab like" antibody in phase 2 development for Alzheimer's. However, he noted that consensus expectations for Eli Lilly's N3pG "were low, rightfully so" and he sees Alzheimer's continuing to be a highly challenging area of drug development. Arfaei has an Outperform rating on Eli Lilly shares.

TODAY'S FREE FLY STORIES

XEC

Cimarex Energy

$68.58

-0.69 (-1.00%)

, REN

Resolute Energy

$0.00

(0.00%)

07:28
05/20/19
05/20
07:28
05/20/19
07:28
Upgrade
Cimarex Energy, Resolute Energy rating change  »

Cimarex Energy upgraded…

XEC

Cimarex Energy

$68.58

-0.69 (-1.00%)

REN

Resolute Energy

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 22

    May

DXC

DXC Technology

$56.32

-1.35 (-2.34%)

07:25
05/20/19
05/20
07:25
05/20/19
07:25
Recommendations
DXC Technology analyst commentary  »

DXC Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

REGN

Regeneron

$304.81

-4.69 (-1.52%)

07:24
05/20/19
05/20
07:24
05/20/19
07:24
Recommendations
Regeneron analyst commentary  »

Barclays still bearish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 14

    Jun

  • 26

    Jun

BYND

Beyond Meat

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Initiation
Beyond Meat initiated  »

Beyond Meat initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$147.06

-1.63 (-1.10%)

07:23
05/20/19
05/20
07:23
05/20/19
07:23
Downgrade
Clorox rating change  »

Clorox downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:22
05/20/19
05/20
07:22
05/20/19
07:22
Downgrade
Bristol-Myers rating change  »

Bristol-Myers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 29

    May

  • 31

    May

SPN

Superior Energy

$2.49

-0.24 (-8.79%)

07:20
05/20/19
05/20
07:20
05/20/19
07:20
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

07:20
05/20/19
05/20
07:20
05/20/19
07:20
General news
FX Update: The dollar has put a mixed performance »

FX Update: The dollar has…

MTSC

MTS Systems

$56.33

-0.13 (-0.23%)

07:18
05/20/19
05/20
07:18
05/20/19
07:18
Recommendations
MTS Systems analyst commentary  »

MTS Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$7.39

-0.62 (-7.74%)

07:17
05/20/19
05/20
07:17
05/20/19
07:17
Hot Stocks
Akoustis announces shipments, production order for 3.8GHz filters »

Akoustis announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

AZN

AstraZeneca

$37.80

0.02 (0.05%)

07:16
05/20/19
05/20
07:16
05/20/19
07:16
Hot Stocks
AstraZeneca reports data from Novel START trial of Symbicort »

New data from Novel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

DE

Deere

$134.82

-11.15 (-7.64%)

07:15
05/20/19
05/20
07:15
05/20/19
07:15
Recommendations
Deere analyst commentary  »

Deere price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

PDCE

PDC Energy

$36.67

-0.55 (-1.48%)

07:13
05/20/19
05/20
07:13
05/20/19
07:13
Hot Stocks
PDC Energy CEO sends letter to shareholders, encourages white proxy card vote »

PDC Energy mailed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

HEI

Heico

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Heico analyst commentary  »

Heico price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 05

    Jun

MU

Micron

$36.06

-1.37 (-3.66%)

07:11
05/20/19
05/20
07:11
05/20/19
07:11
Recommendations
Micron analyst commentary  »

Micron price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

CLI

Mack-Cali Realty

$22.92

-0.12 (-0.52%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Hot Stocks
Mack-Cali Realty recommends stockholders vote the WHITE proxy card »

Mack-Cali strongly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

07:10
05/20/19
05/20
07:10
05/20/19
07:10
General news
Oil prices down from highs over USD 63 »

Oil prices down from…

ZAYO

Zayo Group

$32.70

-0.09 (-0.27%)

07:10
05/20/19
05/20
07:10
05/20/19
07:10
Downgrade
Zayo Group rating change  »

Zayo Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TSLA

Tesla

$211.02

-17.56 (-7.68%)

07:09
05/20/19
05/20
07:09
05/20/19
07:09
Recommendations
Tesla analyst commentary  »

Tesla price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

, MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

07:08
05/20/19
05/20
07:08
05/20/19
07:08
Recommendations
Alnylam, The Medicines Co. analyst commentary  »

Alnylam partner presented…

ALNY

Alnylam

$67.48

-1.52 (-2.20%)

MDCO

The Medicines Co.

$33.01

-0.19 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

SPTN

SpartanNash

$14.94

-0.27 (-1.78%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Earnings
SpartanNash reaffirms FY19 adjusted EPS view $1.20-$1.50, consensus $1.69 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 22

    May

CGEN

Compugen

$3.45

0.01 (0.29%)

, BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

07:07
05/20/19
05/20
07:07
05/20/19
07:07
Hot Stocks
Compugen doses first patient in Phase 1 COM701/Opdivo study »

Compugen (CGEN) announced…

CGEN

Compugen

$3.45

0.01 (0.29%)

BMY

Bristol-Myers

$46.84

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

  • 20

    May

  • 29

    May

  • 31

    May

TRK

Speedway Motorsports

$18.14

-0.035 (-0.19%)

07:06
05/20/19
05/20
07:06
05/20/19
07:06
Hot Stocks
Speedway Motorsports retains advisor to consider going private proposal »

Speedway Motorsports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$104.76

-2.98 (-2.77%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Recommendations
Xilinx analyst commentary at Nomura Instinet »

U.S. action against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$5.29

-0.07 (-1.31%)

07:05
05/20/19
05/20
07:05
05/20/19
07:05
Hot Stocks
Intec Pharma granted European patent »

Intec Pharma announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.